HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis

International Journal of Cancer

Volumn 138, Issue 1, 2016, Pages 45-54

  Rohner, Eliane ^a   Wyss, Natascha ^a   Heg, Zina ^a   Faralli, Zully ^a   Mbulaiteye, Sam M ^b   Novak, Urban ^c   Zwahlen, Marcel ^a   Egger, Matthias ^a,d   Bohlius, Julia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

co infection; HIV; human herpesvirus 8; meta analysis

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HEMOPHILIA; HERPES SIMPLEX; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW; COMPLICATION; HEALTH; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; META ANALYSIS;

COINFECTION; GLOBAL HEALTH; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84944274573     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29687     Document Type: Article

References (43)

1. Bhutani M, Polizzotto MN, Uldrick TS, et al., Kaposi sarcoma-associated herpesvirus-associated malignancies: Epidemiology, pathogenesis, and advances in treatment. Semin Oncol 2015; 42: 223-246.
2. Butler LM, Were WA, Balinandi S, et al., Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis 2011; 203: 625-34.
3. Dollard SC, Butler LM, Jones AM, et al., Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: Insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer 2010; 127: 2395-401.
4. Olsen SJ, Chang Y, Moore PS, et al., Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12: 1921-1.
5. Mbulaiteye SM, Pfeiffer RM, Whitby D, et al., Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003; 187: 1780-1.
6. Plancoulaine S, Abel L, Tregouet D, et al., Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res 2004; 64: 8782-7.
7. Engels EA, Atkinson JO, Graubard BI, et al., Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196: 199-207.
8. Mesri EA, Cesarman E, Boshoff C., Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010; 10: 707-19.
9. Melbye M, Cook PM, Hjalgrim H, et al., Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77: 543-8.
10. Martin JN, Ganem DE, Osmond DH, et al., Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948-54.
11. Dukers NH, Renwick N, Prins M, et al., Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000; 1;151: 213-24.
12. Eltom MA, Mbulaiteye SM, Dada AJ, et al., Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. AIDS 2002; 6;16: 2473-8.
13. Shebl FM, Dollard SC, Pfeiffer RM, et al., Human herpesvirus 8 seropositivity among sexually active adults in Uganda. PLoS One 2011; 6: E21286.
14. de Sanjose S, Mbisa G, Perez-Alvarez S, et al., Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 2009; 199: 1449-56.
15. Chang Y, Cesarman E, Pessin MS, et al., Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
16. Higgins JP, Thompson SG., Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
17. Sterne JA, Juni P, Schulz KF, et al., Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med 2002; 21: 1513-24.
18. The World Bank. Country and Lending Groups [cited 2014 Nov 3]. http://data.worldbank.org/about/country-and-lending-groups
19. Egger M, Davey SG, Schneider M, et al., Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
20. Rohner E, Wyss N, Trelle S, et al., HHV-8 seroprevalence: A global view. Syst Rev 2014; 3: 11.
21. Wakeham K, Webb EL, Sebina I, et al., Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr 2013; 63: 228-33.
22. Yang PR, Tan XH, Guo SX, et al., Research of Kaposi's sarcoma-associated herpesvirus in drug users in one city of Xinjiang. Modern Preventive Medicine 2010; 37: 107-9.
23. Renwick N, Dukers NH, Weverling GJ, et al., Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 2002; 185: 1808-12.
24. He J, Bhat G, Kankasa C, et al., Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis 1998; 178: 1787-90.
25. Cannon MJ, Dollard SC, Smith DK, et al., Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344: 637-43.
26. Casper C, Meier AS, Wald A, et al., Human herpesvirus 8 infection among adolescents in the REACH cohort. Arch Pediatr Adolesc Med 2006; 160: 937-42.
27. Zhang T, Shao X, Chen Y, et al., Human herpesvirus 8 seroprevalence, China. Emerg Infect Dis 2012; 18: 150-2.
28. Engels EA, Whitby D, Goebel PB, et al., Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000; 23: 346-54.
29. Rabkin CS, Schulz TF, Whitby D, et al., Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998; 178: 304-9.
30. Ariyoshi K, Schim van der Loeff M, Cook P, et al., Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1: 193-9.
31. Dedicoat M, Newton R, Alkharsah KR, et al., Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004; 190: 1068-1075.
32. Mercader M, Taddeo B, Panella JR, et al., Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 2000; 156: 1961-71.
33. Aoki Y, Tosato G., HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 2004; 104: 810-4.
34. Caselli E, Galvan M, Santoni F, et al., Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J Gen Virol 2003; 84: 1123-31.
35. Sullivan SG, Hirsch HH, Franceschi S, et al, Swiss HIV Cohort Study. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. AIDS 2010; 24: 2245-2252.
36. Bourboulia D, Aldam D, Lagos D, et al., Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS 2004; 18: 485-493.
37. Pauk J, Huang ML, Brodie SJ, et al., Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343: 1369-77.
38. Taylor MM, Chohan B, Lavreys L, et al., Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 2004; 1;190: 484-8.
39. de Franca TR, de Araujo RA, Ribeiro CM, et al., Salivary shedding of HHV-8 in people infected or not by human immunodeficiency virus 1. J Oral Pathol Med 2011; 40: 97-102.
40. Miller CS, Berger JR, Mootoor Y, et al., High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006; 44: 2409-15.
41. Howard MR, Whitby D, Bahadur G, et al., Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS 1997; 11: F15-F19.
42. Crabtree KL, Wojcicki JM, Minhas V, et al., Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: The role of early childhood feeding practices. Cancer Epidemiol Biomarkers Prev 2014; 23: 300-8.
43. Butler LM, Osmond DH, Jones AG, et al., Use of saliva as a lubricant in anal sexual practices among homosexual men. J Acquir Immune Defic Syndr 2009; 50: 162-7.